Retour
Prix Creative Medical Technology Holdings Inc (CELZ)
Graphique du cours de l'action CELZ
CELZ Gagner
Creative Medical Technology Holdings Inc
$1.92
-1.03%
$-0.02
À partir d'aujourd'hui :Feb 11, 15:05:13 GMT-5
Derniers résultats des bénéfices : Q3 '25
Signalé : 2025-11-07
Bénéfices historiques
Trimestriellement
Annuel
EPS
Revenus
Earnings FAQ
Comment le bénéfice par action récent de CELZ se compare-t-il aux attentes ?
Comment les revenus de Creative Medical Technology Holdings Inc CELZ se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Creative Medical Technology Holdings Inc ?
Quel est le score de qualité des bénéfices pour Creative Medical Technology Holdings Inc ?
Quand Creative Medical Technology Holdings Inc publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Creative Medical Technology Holdings Inc ?
Creative Medical Technology Holdings Inc a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$1.94
Prix d'ouverture
$1.85
Plage de la journée
$1.84 - $1.95
Plage de 52 semaines
$1.5 - $6.9
Volume
55.1K
Volume moyen
108.8K
BPA (TTM)
-2.87
Rendement en dividend
--
Capitalisation boursière
$4.9M
Qu’est-ce que CELZ ?
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The company is headquartered in Phoenix, Arizona and currently employs 4 full-time employees. The company went IPO on 2009-05-01. The firm conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Fonctionnalités
Ressources
© 2025 Finture Development Limited. All rights reserved